Schouten H C, Sizoo W, van 't Veer M B, Hagenbeek A, Löwenberg B
Department of Hematology, Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Bone Marrow Transplant. 1988 Sep;3(5):407-12.
In 22 transplant patients who received T cell-depleted allogeneic bone marrow (alloBMT) we investigated the chimeric state using a mixed agglutination technique and isoenzyme determinations for the red cell lineage, an isoenzyme assay for the myeloid cells, immunoglobulin allotyping for B lymphocytes and cytogenetics for karyotyping. The median duration of follow-up for these patients was 25 months after BMT. Chimerism was evaluated after 6 months. In 14 (64%) of the 22 patients incomplete chimerism was found when the results of the different techniques were combined. Recipient type cells were detected in the red cell lineage in 36% of cases, recipient type myeloid cells in 7% of cases and recipient type mitotic cells in 25% of cases where the marker could provide discrimination. In 100% of the evaluable patients recipient type immunoglobulins persisted after BMT. The data indicate a high frequency of incomplete chimerism following T cell-depleted BMT which involved the broad series of hematological lineages. This frequency appears higher than that following non-T cell-depleted BMT.
在22例接受T细胞去除的异基因骨髓移植(alloBMT)的患者中,我们使用混合凝集技术和红细胞系同工酶测定、髓系细胞同工酶分析、B淋巴细胞免疫球蛋白同种异型分型以及核型分析的细胞遗传学方法来研究嵌合状态。这些患者骨髓移植后的中位随访时间为25个月。在6个月后评估嵌合情况。在22例患者中的14例(64%),当综合不同技术的结果时发现不完全嵌合。在36%的病例中,红细胞系检测到受者型细胞,在7%的病例中检测到受者型髓系细胞,在25%的病例中检测到受者型有丝分裂细胞(其中该标记可用于区分)。在100%可评估的患者中,骨髓移植后受者型免疫球蛋白持续存在。数据表明,T细胞去除的骨髓移植后不完全嵌合的频率较高,涉及广泛的血液学谱系。该频率似乎高于非T细胞去除的骨髓移植后的频率。